Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US COVID-19 Fraud: Licorice Promoted As Treatment, Unapproved Tests Offered OTC
Jun 18 2020
•
By
Malcolm Spicer
Medakit Ltd. in Hong Kong was making its unapproved COVID-19 antibodies test available OTC to US consumers before receiving an FDA warning.
Explore how consumer health is evolving. On the go.
David Ridley hosts in-depth conversations with industry leaders.
More from Compliance
More from Policy & Regulation